Course Description
At least 100 million Americans are living with chronic pain. Treating pain best means addressing pain comprehensively, at the lowest cost and risk, and ensuring that treatments are broadly accessible to patients. More focus has been placed on the realm of behavioral medicine for pain, which works alongside medical treatments and is now being called “empowered pain relief.” Individuals can become equipped with information, skills, and strategies that help them better manage the negative impacts of pain. This can help them reduce aspects of suffering, alter the trajectory of pain, and for some patients can even help reduce the need for medical care. Empowered Relief® is an evidence-based, single-session pain class that rapidly equips patients with pain management skills. The idea is to empower patients as early as possible, ideally before pain becomes an ongoing problem. This presentation will focus on the process of Empowered Relief® as a therapy option for patients with chronic pain and outcomes with this program.
Learning Objectives
- Describe elements of the treatment intervention Empowered Relief® for pain management.
- Explain the impact of Empowered Relief® on patient outcomes.
- Identify potential applications of Empowered Relief®.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
BCPPs desiring an evidence-based focus on an emerging area of practice and contemporary issues in psychiatric pharmacy at the specialist level are the intended audience of this recertification activity. This activity is designed for BCPPs who learn best from didactic presentations, are auditory and visual learners, and/or who learn best from hands-on-learning and dialoguing with specialist faculty and colleagues.
Faculty
View biographical information
Beth Darnall, PhD
Professor, Stanford University School of Medicine; Department of Anesthesiology, Perioperative and Pain Medicine; Director, Stanford Pain Relief Innovations Lab
Palo Alto, CA
Beth Darnall, PhD is Professor at Stanford University School of Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine where she directs the Stanford Pain Relief Innovations Lab. Her pain treatment research is funded by the National Institutes of Health (NIH) and the Patient-Centered Outcomes Research Institute. Her work involves brief, digital, scalable and home-based analgesic interventions. She is creator of Empowered Relief, an evidence-based 1-session skills-based intervention for acute/surgical pain and chronic pain that is delivered in 22 countries and 7 languages. Darnall has three times briefed the U.S. Congress and the FDA on patient-centered pain care, opioid stewardship, and iatrogenic harms from forced opioid tapering. She is a scientific member of the NIH Interagency Pain Research Coordinating Committee, and served as a scientific member of the CDC Opioid Workgroup (2021). She is Chief Science Advisor for AppliedVR, serves on the Board of Directors of the American Academy of Pain Medicine and is on the Medical Advisory Board of the Facial Pain Association. Her work has been featured in outlets such as Scientific American, The Guardian (Australia), NPR Radio, BBC Radio, The Wall Street Journal, The New York Times and Nature. She has authored five books for patients and clinicians. In 2018 she spoke on the psychology of pain relief at the World Economic Forum in Davos, Switzerland.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Date: 10/13/2023
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-23-016-H08-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.